CN Stock MarketDetailed Quotes
300254 Shanxi C&Y Pharmaceutical Group
- 9.43
- +0.06+0.64%
Market Closed Nov 29 15:00 CST
2.34BMarket Cap28.23P/E (TTM)
9.59High9.18Low109.08KlotVolume9.36Open9.37Pre Close102.71MTurnover4.85%Turnover Ratio93.37P/E (Static)248.32MShares11.8652wk High3.62P/B2.12BFloat Cap4.9852wk Low11.24Limit Up225.02MShs Float54.40Historical High7.50Limit Down4.38%Amplitude4.72Historical Low--Dividend TTM9.42Avg Price59.44KlotAsk--Div YieldTTM100Lot Size47.43KlotBid
Shanxi C&Y Pharmaceutical Group Key Stats
All
YOY
| (Q9)Sep 30, 2024 | (Q6)Jun 30, 2024 | (Q3)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q9)Sep 30, 2023 | (Q6)Jun 30, 2023 | (Q3)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q9)Sep 30, 2022 | (Q6)Jun 30, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | ||||||||||
| Goods sale service render cash | -1.70%572.54M | 3.16%382.43M | 7.17%197.66M | -10.35%790.38M | -11.72%582.44M | -13.19%370.7M | -17.31%184.43M | -14.00%881.65M | -13.91%659.8M | -13.87%427.03M |
| Refunds of taxes and levies | ---- | ---- | ---- | -98.50%22.16K | --22.16K | --22.16K | --22.16K | -27.97%1.48M | ---- | ---- |
| Cash received relating to other operating activities | 7.50%30.93M | 34.06%26.55M | 48.21%16.62M | 6.73%73.58M | -3.46%28.77M | -24.93%19.8M | -24.01%11.21M | 22.39%68.94M | -22.10%29.81M | -11.36%26.38M |
| Cash inflows from operating activities | -1.27%603.47M | 4.72%408.98M | 9.51%214.28M | -9.25%863.98M | -11.36%611.23M | -13.87%390.53M | -17.72%195.67M | -12.13%952.07M | -14.30%689.6M | -13.72%453.41M |
| Goods services cash paid | -30.90%96.07M | -35.28%55.41M | -12.71%33.08M | 12.61%174.14M | 29.90%139.02M | 8.68%85.62M | -7.36%37.9M | -12.90%154.63M | -17.81%107.02M | -21.85%78.78M |
| Staff behalf paid | 1.55%138.85M | 5.75%97.51M | -7.00%46.99M | 5.32%175.69M | 13.30%136.72M | 14.47%92.21M | 26.03%50.52M | 2.29%166.81M | -2.85%120.67M | -8.50%80.55M |
| All taxes paid | -2.54%70.5M | -26.38%38.08M | -39.64%19.82M | 28.50%116.47M | 10.74%72.34M | 33.60%51.72M | 52.06%32.83M | -0.76%90.64M | -6.37%65.32M | -7.05%38.71M |
| Cash paid relating to other operating activities | -6.87%234.98M | -1.78%157.5M | -2.57%78.9M | -22.63%359.87M | -24.60%252.32M | -28.42%160.36M | -21.37%80.98M | -16.15%465.11M | -17.06%334.66M | -11.13%224.03M |
| Cash outflows from operating activities | -9.99%540.4M | -10.62%348.5M | -11.59%178.79M | -5.82%826.16M | -4.34%600.4M | -7.62%389.91M | -1.63%202.23M | -11.09%877.19M | -13.75%627.66M | -12.54%422.07M |
| Net cash flows from operating activities | 481.96%63.07M | 9,658.20%60.47M | 640.55%35.49M | -49.50%37.81M | -82.50%10.84M | -98.02%619.72K | -120.37%-6.56M | -22.75%74.88M | -19.54%61.94M | -27.05%31.34M |
| Investing cash flow | ||||||||||
| Cash received from disposal of investments | ---- | ---- | ---- | 253.02%5.19M | 253.74%5.19M | ---- | ---- | -81.11%1.47M | -81.15%1.47M | ---- |
| Net cash received from disposal of fix assets、 intangible assets 、other long-term asset | 201.52%64.1K | 600.74%54.66K | 594.93%19.46K | 4,665.86%100.83M | -98.69%21.26K | -99.52%7.8K | -91.64%2.8K | -67.04%2.12M | -74.58%1.62M | -74.18%1.62M |
| Net cash received from disposal of subsidiaries and other business units | --1.63M | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| Cash received relating to other investing activities | ---- | ---- | ---- | ---- | --100M | --100M | --100M | ---- | ---- | ---- |
| Cash inflows from investing activities | -98.39%1.69M | -99.95%54.66K | -99.98%19.46K | 2,857.49%106.02M | 3,305.58%105.21M | 6,063.81%100.01M | 298,415.82%100M | -74.75%3.58M | -78.18%3.09M | -88.46%1.62M |
| Cash paid to acquire fixed assets intangible assets and other long-term assets | 244.12%61.07M | 207.76%49.24M | 752.36%46.65M | 26.63%33.92M | -32.47%17.75M | -9.34%16M | -39.00%5.47M | -27.47%26.78M | 18.73%26.28M | 30.17%17.65M |
| Cash outflows from investing activities | 244.12%61.07M | 207.76%49.24M | 752.36%46.65M | 26.63%33.92M | -32.47%17.75M | -9.34%16M | -39.00%5.47M | -32.02%26.78M | 17.30%26.28M | 27.62%17.65M |
| Net cash flows from investing activities | -167.88%-59.37M | -158.54%-49.18M | -149.33%-46.63M | 410.80%72.1M | 477.17%87.46M | 624.29%84.01M | 1,157.69%94.53M | 7.96%-23.2M | -181.36%-23.19M | -6,954.39%-16.02M |
| Financing cash flow | ||||||||||
| Cash received from capital contributions | --33.35M | ---- | ---- | ---- | ---- | ---- | ---- | --105.25M | --105.25M | --105.25M |
| Cash from borrowing | 32.21%114.62M | 93.76%70.72M | 6,060.28%61.6M | -67.99%86.95M | -61.07%86.7M | -3.18%36.5M | -75.00%1M | 169.18%271.6M | 259.19%222.7M | -14.32%37.7M |
| Cash received relating to other financing activities | ---- | --1.27M | ---- | --28.8M | ---- | ---- | ---- | ---- | ---- | ---- |
| Cash inflows from financing activities | 70.67%147.97M | 97.25%72M | 6,060.28%61.6M | -69.29%115.75M | -73.56%86.7M | -74.47%36.5M | -75.00%1M | 271.72%376.85M | 421.55%327.95M | 218.52%142.95M |
| Borrowing repayment | -7.00%78.08M | 245.03%53.34M | 723.60%41.18M | -43.96%125.21M | -50.69%83.96M | -63.50%15.46M | 61.29%5M | 17.89%223.42M | 49.01%170.26M | -44.45%42.36M |
| Dividend interest payment | -13.16%8.99M | -12.79%5.97M | -14.39%2.93M | -57.68%13.31M | -36.06%10.36M | -36.59%6.84M | -56.61%3.42M | 3.12%31.46M | -40.73%16.2M | -42.48%10.79M |
| -Including:Cash payments for dividends or profit to minority shareholders | ---- | ---- | ---- | ---- | ---- | ---- | ---- | 23.51%19.56M | -52.27%7.56M | -53.86%5M |
| Cash payments relating to other financing activities | -90.59%20.12M | 122.78%11.47M | 160.31%6.44M | 2,228.72%219M | 2,625.80%213.92M | -1.96%5.15M | 107.64%2.47M | -72.05%9.4M | -73.65%7.85M | -70.03%5.25M |
| Cash outflows from financing activities | -65.22%107.2M | 157.83%70.78M | 364.05%50.55M | 35.28%357.52M | 58.64%308.24M | -53.00%27.45M | -10.50%10.89M | 4.18%264.29M | 13.38%194.3M | -48.11%58.4M |
| Net cash flows from financing activities | 118.40%40.77M | -86.54%1.22M | 211.76%11.06M | -314.79%-241.77M | -265.76%-221.54M | -89.30%9.05M | -21.09%-9.89M | 173.91%112.56M | 223.18%133.65M | 224.95%84.55M |
| Net cash flow | ||||||||||
| Net increase in cash and cash equivalents | 136.09%44.47M | -86.65%12.51M | -100.11%-85.49K | -180.28%-131.85M | -171.49%-123.24M | -6.19%93.68M | 416.53%78.07M | 303.82%164.24M | 533.67%172.4M | 508.10%99.86M |
| Add:Begin period cash and cash equivalents | -49.97%131.99M | -49.97%131.99M | -49.97%131.99M | 164.89%263.85M | 164.89%263.85M | 164.89%263.85M | 164.89%263.85M | -44.72%99.61M | -44.72%99.61M | -44.72%99.61M |
| End period cash equivalent | 25.50%176.47M | -59.58%144.5M | -61.42%131.91M | -49.97%131.99M | -48.31%140.61M | 79.24%357.52M | 198.05%341.92M | 164.89%263.85M | 93.69%272M | 28.10%199.47M |
| Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
| Accounting Standards | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) |
| Audit Opinions | -- | -- | -- | Unqualified opinion | -- | -- | -- | Unqualified opinion | -- | -- |
| Auditor | -- | -- | -- | Lixin Certified Public Accountants (Special General Partnership) | -- | -- | -- | Lixin Certified Public Accountants (Special General Partnership) | -- | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.
Analysis
Price Target
No Data
Heat List
CN
Overall
Symbol
Latest Price
% Chg
No Data